Get started
Author

Caroline Goldin

Reducing the receipt of contraindicated medications in patients with Parkinson disease
2023 · Caroline Goldin, Stefan Sillau, et al. · Frontiers in Aging Neuroscience · 9
PDF
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas
2024 · Rahul S. Bhansali, Fredrik Ellin, et al. · Blood Advances · 4
A Multi-Institutional Retrospective Analysis of T-Cell Lymphomas with Central Nervous System Relapse
2021 · Rahul S. Bhansali, Nivetha Ganesan, et al. · Blood · 3
CNS Relapse in T-Cell Lymphoma Index: A Risk Score to Predict Central Nervous System Relapse in Patients with T-Cell Lymphomas
2022 · Rahul S. Bhansali, Fredrik Ellin, et al. · Blood · 2
MYB-altered Diffuse Astrocytoma Identified in an Atypical Population (P10-6.002)
2026 · James Cochran, Caroline Goldin, et al. · Neurology
A phase 2 double-blind, randomized, prospective, placebo-controlled study of NanO₂ combined with radiation and temozolomide in patients with newly diagnosed glioblastoma: RESTORE.
2026 · Samuel A. Goldlust, Michael A. Badruddoja, et al. · Journal of Clinical Oncology
CTNI-78. A phase 2 double-blind, randomized, prospective, placebo-controlled study of NanO₂TM combined with radiation and temozolomide in patients with newly diagnosed glioblastoma: RESTORE
2025 · Michael Badruddoja, Crystal Placencia, et al. · Neuro-Oncology
PDF
Ctni-30. a Phase 2 Double-blind, Randomized, Prospective, Placebo Controlled Study of Nano₂tm Combined With Radiation and Temozolomide in Patients With Newly-diagnosed Glioblastoma: Restore
2024 · Michael A Badruddoja, Crystal Placencia, et al. · Neuro-Oncology
PDF
Reducing the Receipt of Contraindicated Medications for Patients with Parkinson’s Disease (P10-11.001)
2023 · Caroline Goldin, Elisa Worledge, et al. · Neurology
Works count: 9
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type